Clinical

Dataset Information

0

Feasibility study of adjuvant chemotherapy with FOLFOX(or XELOX) for 3 months followed by oral anticancer drug for 3 months in patients with completely resected colorectal cancer


ABSTRACT: Interventions: mFOLFOX6 therapy(or XELOX therapy) for 3 months followed by capecitabine for 3 months mFOLFOX6 therapy Day1 L-OHP 85mg/m2,l-LV 200mg/m2 Day1 bolus 5FU 400mg/m2 Day1~2 Infusional 5FU 2400mg/m2 XELOX therapy Day1 L-OHP 130mg/m2 Day1~14(b.i.d. at the end of meal) capecitabine 2000mg/m2/day Capecitabine therapy Day1~14(b.i.d. at the end of meal) Capecitabine 2500mg/m2/day Primary outcome(s): Frequency and Grade of peripheral neuropathy(CTCAE v4 and PNQ) Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2620377 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2628675 | ecrin-mdr-crc
2024-09-01 | E-MTAB-13741 | biostudies-arrayexpress
| 2619736 | ecrin-mdr-crc
2024-06-01 | GSE266932 | GEO
| 2620624 | ecrin-mdr-crc
| 2622964 | ecrin-mdr-crc
| 2622614 | ecrin-mdr-crc
| 2620254 | ecrin-mdr-crc
| 2621954 | ecrin-mdr-crc
| 2626922 | ecrin-mdr-crc